Concepedia

M. Gorre

MG

Statistics

Publications

19

Citations

1.5K

H-Index

16

Active since

1997

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

CombiMatrix

Quest Diagnostics (United States)

University of California, Los Angeles

The University of Texas at San Antonio Health Science Center

M. Gorre is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, molecular oncology, and oncology.

Publications per year

1997–2011

19

Publications

19

BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90

M. Gorre, Katharine Ellwood‐Yen, Gabriela Chiosis et al. · Blood · 2002 · 278 citations · Full text

, , +9

Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop

S. A. Roumiantsev, Neil P. Shah, M. Gorre et al. · Proceedings of the National Academy of Sciences · 2002 · 258 citations · Full text

, , +15

Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants

Brian J. Skaggs, M. Gorre, Michael R. Burgess et al. · Proceedings of the National Academy of Sciences · 2006 · 146 citations

, , +15

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

I‐Tien Yeh, Mathew A Martin, Ryan S. Robetorye et al. · Modern Pathology · 2009 · 144 citations · Full text

, , +13

A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.

David R Huron, M. Gorre, Alan J. Kraker et al. · PubMed · 2003 · 118 citations

, , +15

1–5 of 19